Skip to main content
Clinical Trials/NCT04796181
NCT04796181CompletedNot Applicable

Single Center, Single Blinded, Prospective Validation Study for the Accuracy and Safety Evaluation of Neteera 130H, a Novel, Radar-based Contact-free Device for Heart and Respiratory Rate Measurements

Neteera Technologies Ltd.2 sites in 2 countries170 target enrollmentStarted: February 21, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
170
Locations
2
Primary Endpoint
Proportion of accurate spot HR while the Neteera 130H located behind the subject.

Study Overview

Brief Summary

A single center, single blinded, prospective validation (including extension0 study for the accuracy and safety evaluation of Neteera 130H, a novel, radar-based contact-free device for heart and respiratory rate measurements.

Detailed Description

This is a single-blinded, prospective validation study for the accuracy and safety evaluation of Neteera 130H, a novel, radar-based contact-free device for heart and respiratory rate measurements compared to reference devices.

Each subject will have a single study visit in which the subjects will be screened and upon eligibility confirmation, will undergo HR and RR measurements using the investigational device as well as the reference devices. In a previous clinical trial (NET-MED-002) 100 subjects were measured in the sitting position. In the extension study part (NET-MED-002-EXT), 70 eligible subjects, 18 years old and above, suffering from chronic medical conditions, will be enrolled. In this extension part, 70 of the subjects will be measured while randomly assigned into one of two groups - 35 subjects in group A (sitting position) and 35 subjects in sleep posture//group B (lying in bed/sleeping posture position) in a ratio of 1:1. Data from the previous study and the Extension study will be pooled for final analysis.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Proportion of accurate spot HR while the Neteera 130H located behind the subject.

Time Frame: During 60 seconds, from t = 0:00 min to t = 1:00

Proportion of accurate spot HR (BPM) measurements of the investigated device, while located behind the subject, in sitting position compared to the reference device measurements

Proportion of accurate spot RR while the Neteera 130H located behind the subject.

Time Frame: During 60 seconds, from t = 0:00 min to t = 1:00

Proportion of accurate spot RR (BrPM) measurements of the investigated device in sitting position, while located behind the subject, compared to reference device (capnograph) measurements

Secondary Outcomes

  • Repeating the primary endpoints in sitting position while the investigated device is located in front of the subject.(During 60 seconds, from t = 0:00 min to t = 1:00)
  • Repeating previous endpoint positions (where applicable) comparing investigated device continuous HR and RR measurements to reference device continuous measurements(During 5 minutes of the continuous measurement)
  • Repeating the previous endpoints (where applicable) in sleep posture/lying in bed position, while the investigated device is located above of the subject.(During 60 seconds)

Investigators

Sponsor
Neteera Technologies Ltd.
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Heart Rate and Respiratory Rate... | Clinical Trial